It is well documented that the loss of p53 can induce tumor formation in mice, whereas its restoration often leads to a rapid regression of established in situ tumors [8], showcasing the anticancer therapeutic potential of p53 reactivation. This evidence concerns the gene TP53 and neoplasm.